Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An endocrine society* clinical practice guideline

Phyllis W. Speiser, Wiebke Arlt, Richard J. Auchus, Laurence S. Baskin, Gerard S. Conway, Deborah P. Merke, Heino F.L. Meyer-Bahlburg, Walter L. Miller, M. Hassan Murad, Sharon E. Oberfield, Perrin C. White

Research output: Contribution to journalArticle

155 Scopus citations

Abstract

Objective: To update the congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency clinical practice guideline published by the Endocrine Society in 2010. Conclusions: The writing committee presents updated best practice guidelines for the clinical management of congenital adrenal hyperplasia based on published evidence and expert opinion with added considerations for patient safety, quality of life, cost, and utilization.

Original languageEnglish (US)
Pages (from-to)4043-4088
Number of pages46
JournalJournal of Clinical Endocrinology and Metabolism
Volume103
Issue number11
DOIs
StatePublished - 2018

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Fingerprint Dive into the research topics of 'Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An endocrine society* clinical practice guideline'. Together they form a unique fingerprint.

  • Cite this

    Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Hassan Murad, M., Oberfield, S. E., & White, P. C. (2018). Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An endocrine society* clinical practice guideline. Journal of Clinical Endocrinology and Metabolism, 103(11), 4043-4088. https://doi.org/10.1210/jc.2018-01865